Abstract:Objective To observe correlation of magnetic resonance imaging( MRI) features and Ki-67 index in high-grade meningioma with recurrence of tumors. Methods The data of MRI and Ki-67index of 30 patients with high-grade meningiomas of Beijing Sanbo Brain Hospital from Mar. 2008 to Jul. 2011were analyzed. The cystic components in tumor,vital brain structure involved including dural sinus,brain arterial trunk or optic nerve,communication tumor and multiple lesions were detected by MRI. The patients were divided into two groups of < 10% and ≥ 10% of Ki-67. According to the average diameter after enhancement,the lesions were divided into group 1( diameter≤30 mm),group 2( 30 mm < diameter≤40mm),group 3( 40 mm < diameter ≤50 mm),group 4( diameter > 50 mm). The dependent variable was whether the tumor recurrenced,the independent variables was tumor grade,groups of Ki-67 index and tumor size,vital brain structures involved,cystic components and multiple lesions,the logistic regression analysis was performed to determine risk factors of meningioma recurrence. Thirteen patients of recurrent meningiomas with previous history and histologic grade were analysed. All data was processed by SPSS 13. 0 statistical software,Ki-67 proliferation index of gradeⅡ and Ⅲ meningiomas were compared by t-test. Tumor grade,Ki-67 proliferation index,whether involving vital structures or whether it was communication tumor,whether it was skull base lesions,frequently occurring lesions,cystic lesions between recurrence group and no recurrence group of grade Ⅱ and Ⅲ meningiomas was tested and compared by chi-square.Results According to meningioma grading standard constituted by WHO in 2007,there were 13 grade Ⅱ( atypical) and 17 gradeⅢ( anaplastic) meningiomas in the study. There were 16 patients with recurrence meningiomas included 3 gradeⅡand 13 gradeⅢ,and 14 patients with non recurrence meningiomas included10 gradeⅡand 4 gradeⅢ. Ki-67 index of grade 3 meningiomas( 12. 6% ± 8. 5%) was significantly higher than that of grade 2( 5. 7% ± 4. 3%)( t = 2. 695,P = 0. 013). Ki-67 index of the recurrent group( 12. 3% ±8. 4%) was markedly higher than that of non-recurrent group( 6. 6% ± 5. 7%)( t = 2. 123,P = 0. 043). There were significantly difference between detected rate of vital brain structure involved in the recurrence( 62. 5%) and non-recurrent group( 21. 4%)( χ2= 5. 129,P = 0. 024). Logistic regression analysis showed that recurrence risk of meningioma was increasing with grade increasing( χ2= 5. 025,P = 0. 025),vital brain structure involved( χ2= 4. 527,P = 0. 033) and tumor size increasing( χ2= 4. 158,P = 0. 041). Grade 3 tumor recurrent risk was 87 times of grade 2( OR = 87. 950). The recurrence risk of vital brain structural involved was 65 times of non-involved( OR = 64. 590). The tumor recurrence risk increased 4 times as the diameter of a tumor increased one grade( OR = 5. 041). The average recurrence durations from gradeⅠto grade Ⅱ and from gradeⅡto gradeⅢ in 13 recurrent meningiomas showed 86. 3 months and 22. 7 months,respectively. The average recurrence duration of grade Ⅲ meningioma was 17 months. Conclusions A vital brain structure involved and large tumor size increase risk of meningioma relapse. Ki-67 index can act as a predictor of the tumor recurrence. The higher the grade of meningiomas,the higher recurrent rate and the shorter duration of recurrence will be.

Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein

Factors Related to the Post-operative Recurrence of Atypical Meningiomas

Expression of Human MCM6 and DNA Topo II α in craniopharyngiomas and its correlation with recurrence of the tumor

Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.

A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence

Epco-39. Multiomic And Clinical Analysis Of Multiply Recurrent Meningiomas Reveals Risk Factors, Underlying Biology, And Insights Into Evolution

[Expression of Minichromosome Maintenance Protein 6 in Craniopharyngioma and Its Correlation with Prognosis].

Biom-16. A Targeted Gene Expression Biomarker Predicts Low Grade Meningioma Recurrence And Overall Survival

Ki-67 index as a predictive marker of meningioma recurrence following surgical resection

A Microrna Expression Signature Predicts Meningioma Recurrence

MRI features and tumor-infiltrating CD8 + T cells-based nomogram for predicting meningioma recurrence risk

The Correlation Between Recurrence and the Expression of Ki-67 and P53 in Meningiomas

Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk

WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index

Path-28. Ki-67 Index As A Predictive Marker Of Meningioma Recurrence Following Surgical Resection

The Development of a Combined Clinico-Radiomics Model for Predicting Post-Operative Recurrence in Atypical Meningiomas: a Multicenter Study

Correlation analysis of magnetic resonance imaging features and Ki-67 index in high-grade meningioma with recurrence of tumors

MRI features and pathologic types of benign meningiomas and their correlation with tumor recurrence

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma

Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours

Predicting the Probability of Meningioma Recurrence in the Preoperative and Early Postoperative Period: A Multivariate Analysis in the Midterm Follow-Up